Modified recombinant human erythropoietin with potentially reduced immunogenicity. Susantad T, Fuangthong M, Tharakaraman K, Tit-Oon P, Ruchirawat M, Sasisekharan R. Sci Rep. 2021 Jan 15;11(1):1491.

15 Jan 2021
0

Modified recombinant human erythropoietin with potentially reduced immunogenicity.

Susantad T, Fuangthong M, Tharakaraman K, Tit-Oon P, Ruchirawat M, Sasisekharan R.

Sci Rep. 2021 Jan 15;11(1):1491.

Tags

Share this

Related Posts

Molecular characterization of Thai patients with phenylalanine hydroxylase deficiency and in vitro functional study of two novel PAH variants. Ngiwsara L, Vatanavicharn N*, Sawangareetrakul P, Liammongkolkul S, Ratanarak P, Boonyawat B, Srisomsap C, Champattanachai V, Ketudat-Cairns J, Wasant P, Svasti J. Mol Biol Rep. 2021 Mar;48(3):2063-2070.

Recent Posts